Records containing: HIV Infections
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2014-10-10Perinatal Core Protocol
-
CLINICAL_TRIALS study record update · 2014-10-10Changes in Lipid Profiles and Safety of Raltegravir Based Antiretroviral Therapy in HIV-1-infected Patients With Hyperlipidemia While on Current Standard Therapy
-
CLINICAL_TRIALS study record update · 2014-10-09Effectiveness of HIV Viral Load Monitoring of Patient Outcome in Resource-Poor Settings
-
CLINICAL_TRIALS study record update · 2014-10-07Reducing HIV Risk Among Episodic Substance Using Men Who Have Sex With Men (SUMSM): Adaptation of the Personalized Cognitive Counseling (PCC) Intervention
-
CLINICAL_TRIALS study record update · 2014-10-01A Non-Randomized, Open Label, Study to Assess Hepatitis C Viral Kinetics in Predicting the Clinical Response in Patients With Hepatitis C Infection Coinfected With HIV-1 Treated With Peginterferon Alpha-2b and Ribavirin
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2014-09-29Qualitative Assessment of Implementing Routine Rapid HIV Testing
-
CLINICAL_TRIALS study record update · 2014-09-29An Open Label Multinational Study of the Effects of Three Dose Pairs of Tipranavir/Ritonavir (b.i.d.) on the Pharmacokinetic Characteristics of Protocol -Defined, Baseline, Triple Drug Nucleoside and Non-nucleoside Reverse Transcriptase Inhibitor Therapy in HIV-1-infected Subjects.
-
CLINICAL_TRIALS study record update · 2014-09-26ClinicalTrials.gov study NCT00777426
-
CLINICAL_TRIALS study record update · 2014-09-26ClinicalTrials.gov study NCT00713752
-
CLINICAL_TRIALS study record update · 2014-09-26ClinicalTrials.gov study NCT00782808
-
CLINICAL_TRIALS study record update · 2014-09-25Safety Study of Maraviroc's Effect on Human Osteoclasts
-
CLINICAL_TRIALS study record update · 2014-09-25Tipranavir (PNU-140690): A Fourteen Day Dose-response Study Using a Prototype Self-emulsifying Drug Delivery System (SEDDS) Formulation in Treatment-naive HIV-1 Infected Patients. Report on the Post-study Option, a 46-week Treatment Period of Triple Therapy With Delavirdine, ZDV and 3TC Without Tipranavir
-
CLINICAL_TRIALS study record update · 2014-09-18CIDRZ 1234 - Non-virologic Methods to Diagnose Treatment Eligibility in HIV-exposed Infants
-
CLINICAL_TRIALS study record update · 2014-09-18CT to Assess the Effect on the Subcutaneous Fat of Change of EFV for LPV/r in HIV-infected Patients Who Developed Lipoatrophy and Remains Despite Treatment With Efavirenz and Fixed-dose Combination of no Thymidine Nucleoside Analogues.
-
CLINICAL_TRIALS study record update · 2014-09-17HIV Prevention for STD Clinic Patients
-
CLINICAL_TRIALS study record update · 2014-09-15Tipranavir: An Open-label, Randomized Study Comparing Combination Therapy (Tipranavir and Ritonavir vs. Saquinavir and Ritonavir) Used With Two Nucleoside Reverse Transcriptase Inhibitors in Single Protease Inhibitor-experienced HIV-1 Patients
-
CLINICAL_TRIALS study record update · 2014-09-12Tipranavir Disodium: An Open-Label ExploratorySstudy of Tipranavir and Ritonavir in Combination With One Nucleoside Reverse Transcriptase Inhibitor and One Non-Nucleoside Reverse Transcriptase Inhibitor in Multiple Protease Inhibitor-Experienced HIV Patients
-
CLINICAL_TRIALS study record update · 2014-09-12Effect of Encapsulation Upon Efavirenz Pharmacokinetics
-
CLINICAL_TRIALS study record update · 2014-09-08Evaluation of Safety and Efficacy of Raltegravir/Darunavir Combination in Antiretroviral-Naive Patients
-
CLINICAL_TRIALS study record update · 2014-09-05Randomised, Double Blind, Placebo-controlled Dose Ranging Trial to Determine the Antiviral Activity and Safety of Alovudine in Nucleoside-experienced HIV-infected Subjects Experiencing Virologic Failure
-
CLINICAL_TRIALS study record update · 2014-09-05A Phase II, Double Blind, Randomized, Exploratory Study of Chloroquine for Reducing HIV-Associated Immune Activation
-
CLINICAL_TRIALS study record update · 2014-09-03Acupuncture and Relaxation Response for GI Symptoms and HIV Medication Adherence
-
CLINICAL_TRIALS study record update · 2014-09-01Effect of Steady State TPV/r 500 mg/200 mg on Intracellular Concentrations of Zidovudine Triphosphate and Carbovir Triphosphate
-
CLINICAL_TRIALS study record update · 2014-08-27A Randomized Clinical Trial Assessing Continuous HAART Versus Interrupted HAART in a Resource Poor Clinic
-
CLINICAL_TRIALS study record update · 2014-08-22Evaluation of Atazanavir Substitution Intervention (EASI) Study: An Observational Phase IV Study to Evaluate the Impact of Atazanavir Substitution on the Quality of Life and Maintenance of Virologic Suppression in HIV-Infected Patients Intolerant to Current Successful HAART